NCT06641908
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06641908
Title Anti-GD2 ADC M3554 in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | CHE | BEL

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc WITHDRAWN New York New York 10022 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
UZ Leuven RECRUITING Leuven Belgium Details
Institut Bergonié - Service d'Oncologie Médicale RECRUITING Bordeaux France Details
Centre Oscar Lambret - cancerologie generale RECRUITING Lille France Details
Centre Leon Berard - Service d'Oncologie Medicale NOT_YET_RECRUITING Lyon France Details
Centre Antoine Lacassagne - Service d'Hématologie Oncologie NOT_YET_RECRUITING Nice France Details
National Cancer Center Hospital RECRUITING Chūōku Japan Details
Universitaetsspital Zuerich - Klinik fuer Neurologie NOT_YET_RECRUITING Zurich 8091 Switzerland Details
Royal Marsden Hospital-Sutton - Dept of Oncology (Surrey) RECRUITING Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field